These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36035309)

  • 21. Gastrointestinal Manifestations of Coronavirus Disease 2019 Across the United States: A Multicenter Cohort Study.
    Patel AP; Sanders TK; Prakash P; Law J; Alvencar S; Choi A; Shah J; Patel K; Srivoleti P; Chauhan K; Weissman S; Holzwanger E; Dhingra R; Nguyen M; Kim D; Sidhu T; Stallwood C; Dickstein A; Parekh N; Altayar O; Ciorba MA; Yu J; Chen LA; Tabibian JH; Limketkai BN
    Gastro Hep Adv; 2022; 1(6):909-915. PubMed ID: 35874930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical, epidemiological, laboratory, and radiological characteristics of novel Coronavirus (2019-nCoV) in retrospective studies: A systemic review and meta-analysis.
    Kouhsari E; Azizian K; Sholeh M; Shayestehpour M; Hashemian M; Karamollahi S; Yaghoubi S; Sadeghiifard N
    Indian J Med Microbiol; 2021 Jan; 39(1):104-115. PubMed ID: 33610239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A systematic review and meta-analysis protocol examining the clinical characteristics and epidemiological features of olfactory dysfunction (OD) in coronavirus disease 2019 (COVID-19).
    Tan RQ; Li WTV; Shum WZ; Chu SC; Li HL; Shea YF; Chung TW
    Syst Rev; 2021 Mar; 10(1):73. PubMed ID: 33691796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interventions for palliative symptom control in COVID-19 patients.
    Andreas M; Piechotta V; Skoetz N; Grummich K; Becker M; Joos L; Becker G; Meissner W; Boehlke C
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD015061. PubMed ID: 34425019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global prevalence of prolonged gastrointestinal symptoms in COVID-19 survivors and potential pathogenesis: A systematic review and meta-analysis.
    Yusuf F; Fahriani M; Mamada SS; Frediansyah A; Abubakar A; Maghfirah D; Fajar JK; Maliga HA; Ilmawan M; Emran TB; Ophinni Y; Innayah MR; Masyeni S; Ghouth ASB; Yusuf H; Dhama K; Nainu F; Harapan H
    F1000Res; 2021; 10():301. PubMed ID: 34131481
    [No Abstract]   [Full Text] [Related]  

  • 26. Gastrointestinal Manifestations of Pediatric Coronavirus Disease and Their Relationship with a Severe Clinical Course: A Systematic Review and Meta-analysis.
    Bolia R; Dhanesh Goel A; Badkur M; Jain V
    J Trop Pediatr; 2021 May; 67(2):. PubMed ID: 34050766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastrointestinal predictors of severe COVID-19: systematic review and meta-analysis.
    Aziz M; Haghbin H; Lee-Smith W; Goyal H; Nawras A; Adler DG
    Ann Gastroenterol; 2020; 33(6):615-630. PubMed ID: 33162738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19 induces gastrointestinal symptoms and affects patients' prognosis.
    Jin S; Lu X; Xu C
    J Int Med Res; 2022 Oct; 50(10):3000605221129543. PubMed ID: 36238995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Features of COVID-19 and Factors Associated with Severe Clinical Course: A Systematic Review and Meta-analysis.
    Kumar A; Arora A; Sharma P; Anikhindi SA; Bansal N; Singla V; Khare S; Srivastava A
    SSRN; 2020 Apr; ():3566166. PubMed ID: 32714109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastrointestinal Manifestations and Their Association with Neurologic and Sleep Problems in Long COVID-19 Minority Patients: A Prospective Follow-Up Study.
    Ashktorab H; Challa SR; Singh G; Nanduri S; Ibrahim M; Martirosyan Z; Whitsell P; Chirumamilla LG; Shayegh N; Watson K; Smith T; Ogwo V; Kolawole O; Littleton M; Morrison N; Nair V; Byer D; Dawodu DO; Lexima P; Rashid M; Deverapalli M; Atluri SM; Nezamloo A; Nasrin F; Kim RJ; Sherif Z; Oskrochi G; Carethers JM; Brim H
    Dig Dis Sci; 2024 Feb; 69(2):562-569. PubMed ID: 38135813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract.
    Galanopoulos M; Gkeros F; Doukatas A; Karianakis G; Pontas C; Tsoukalas N; Viazis N; Liatsos C; Mantzaris GJ
    World J Gastroenterol; 2020 Aug; 26(31):4579-4588. PubMed ID: 32884218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastrointestinal Manifestations and Outcomes of COVID-19: A Comprehensive Systematic Review and Meta-analysis.
    Mehta D; Kelkar R; Patel N; Trivedi PD; Dawoodi S; Patel D; Solanki D; Hussain A; Nagaraj S; Khayat A; Samala Venkata V; Mansuri U; Patel UK; Sacks H; Atreja A
    Cureus; 2023 Oct; 15(10):e47028. PubMed ID: 37965386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastroenterological and hepatic manifestations of patients with COVID-19, prevalence, mortality by country, and intensive care admission rate: systematic review and meta-analysis.
    Shehab M; Alrashed F; Shuaibi S; Alajmi D; Barkun A
    BMJ Open Gastroenterol; 2021 Mar; 8(1):. PubMed ID: 33664052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative Study on Clinical Characteristics of COVID-19 Patients with or without Digestive Symptoms in Razi Hospital, Ahvaz, Khuzestan.
    Khedri R; Moghadam HB; Kooti W; Delirrooyfard A; Amini P; Maniati M; Garmsiri V; Tabibi M; Jalalian L; Nouri M; Seyedian SS; Masoumi K; Javdanzadeh K
    Endocr Metab Immune Disord Drug Targets; 2023; 23(5):647-671. PubMed ID: 36125828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gastrointestinal and Hepatological Manifestations in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results from the Major COVID Hospital in Serbia.
    Mijac D; Vucelj S; Todorovic K; Vojnovic M; Milicic B; Lukic S; Filipovic B; Marjanovic Haljilji M; Popovic D; Adzic Vukicevic T
    Microorganisms; 2023 Dec; 12(1):. PubMed ID: 38257854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The characteristics of gastrointestinal symptoms in patients with severe COVID-19: a systematic review and meta-analysis.
    Hayashi Y; Wagatsuma K; Nojima M; Yamakawa T; Ichimiya T; Yokoyama Y; Kazama T; Hirayama D; Nakase H
    J Gastroenterol; 2021 May; 56(5):409-420. PubMed ID: 33759041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Favipiravir for treating patients with novel coronavirus (COVID-19): protocol for a systematic review and meta-analysis of randomised clinical trials.
    Arab-Zozani M; Hassanipour S; Ghoddoosi-Nejad D
    BMJ Open; 2020 Jul; 10(7):e039730. PubMed ID: 32737100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastrointestinal symptoms are associated with severity of coronavirus disease 2019: a systematic review and meta-analysis.
    Zeng W; Qi K; Ye M; Zheng L; Liu X; Hu S; Zhang W; Tang W; Xu J; Yu D; Wei Y
    Eur J Gastroenterol Hepatol; 2022 Feb; 34(2):168-176. PubMed ID: 33470700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic.
    Rogers JP; Chesney E; Oliver D; Pollak TA; McGuire P; Fusar-Poli P; Zandi MS; Lewis G; David AS
    Lancet Psychiatry; 2020 Jul; 7(7):611-627. PubMed ID: 32437679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastrointestinal manifestations of COVID-19: An updated systematic review.
    Alzahrani OR; Alanazi AD; Hawsawi YM; Alatwi HE; Alharbi AA
    Trop Biomed; 2022 Sep; 39(3):428-433. PubMed ID: 36214440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.